Interleukin-15 are associated with insulin resistance in postmenopausal women with metabolic syndrome

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorOeste Paulista University–UNOESTE-
Autor(es): dc.contributorFederal University of Triangulo Mineiro–UFTM-
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorOrsatti, Claudio Lera-
Autor(es): dc.creatorOrsatti, Fabio Lera-
Autor(es): dc.creatorBezerra, Thaiz Geovana-
Autor(es): dc.creatorQuevedo, Ana-
Autor(es): dc.creatorNahas, Eliana Aguiar Petri-
Data de aceite: dc.date.accessioned2025-08-21T16:04:15Z-
Data de disponibilização: dc.date.available2025-08-21T16:04:15Z-
Data de envio: dc.date.issued2023-03-01-
Data de envio: dc.date.issued2023-03-01-
Data de envio: dc.date.issued2021-12-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1080/09513590.2022.2105832-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/241448-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/241448-
Descrição: dc.descriptionObjective: To determine if higher levels of circulating interleukin (IL)-15 are positively associated with improvement in insulin resistance in postmenopausal women (PW) with metabolic syndrome (MS). Methods: According to the median value of IL-15 at baseline, PW older than or equal to 45 years were divided into two groups: higher (n = 43) and lower (n = 42) IL-15. There was a 9-month follow-up period with clinical assessments at baseline and at 9 months (criteria of metabolic syndrome, body fat, and insulin resistance). Insulin resistance (IR) was calculated according to the Homeostasis Model Assessment-estimated insulin resistance (HOMA-IR). For IL-1β, IL-6, IL-10, IL-13, IL-33, IL-15, and TNF-α was determined using immunoassay Magnetic Bead Panel. Results: There was an interaction between the time and group only for insulin (p =.008) and HOMA-IR (p =.024). After adjusting for confounding variables (clinical and ILs), the HOMA-IR (p =.006) and insulin (p =.003) were lower in the higher-IL-15 group [HOMA-IR: 2.2 (95% CI: 1.9–2.5) and insulin: 9.1 µIU/mL (95% CI: 7.9–10.3)] when compared to the lower-IL-15 group [HOMA-IR: 3.1 (95% CI: 2.6–3.6) and insulin: 12.9 (95% CI: 11.1–14.9)] after 9 months of follow-up. Conclusion: Higher levels of circulating IL-15 are positively associated with improvements in IR in PW with MS.-
Descrição: dc.descriptionDepartment Health Science Oeste Paulista University–UNOESTE, SP-
Descrição: dc.descriptionApplied Physiology Nutrition and Exercise Research Group–PhyNEr Institute of Health Sciences Federal University of Triangulo Mineiro–UFTM, Minas Gerais-
Descrição: dc.descriptionDepartment of Gynecology and Obstetrics Botucatu Medical School Sao Paulo State University-UNESP, São Paulo-
Descrição: dc.descriptionDepartment of Gynecology and Obstetrics Botucatu Medical School Sao Paulo State University-UNESP, São Paulo-
Idioma: dc.languageen-
Relação: dc.relationGynecological Endocrinology-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectcytokine-
Palavras-chave: dc.subjectInsulin resistance-
Palavras-chave: dc.subjectinterleukin-15-
Palavras-chave: dc.subjectmetabolic syndrome-
Palavras-chave: dc.subjectpostmenopausal-
Título: dc.titleInterleukin-15 are associated with insulin resistance in postmenopausal women with metabolic syndrome-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.